Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K1 | Q02750 | 20/20 | 0.61 |
| ▸ | RAF1 | P04049 | 17/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL961051 | 0.89 | MAP2K1 (0.72) | MAP2K1RAF1 | |
| SCHEMBL959561 | 0.89 | MAP2K1 (0.63) | MAP2K1RAF1CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL959933 | 0.84 | MAP2K1 (0.71) | MAP2K1RAF1CYP3A4CYP2C9 | |
| SCHEMBL959181 | 0.84 | MAP2K1 (0.80) | MAP2K1RAF1 | |
| SCHEMBL961264 | 0.78 | MAP2K1 (0.85) | MAP2K1RAF1CYP3A4CYP2C9 | |
| SCHEMBL960362 | 0.77 | MAP2K1 (0.74) | MAP2K1RAF1 | |
| SCHEMBL961410 | 0.77 | MAP2K1 (0.83) | MAP2K1RAF1CYP3A4CYP2C9 | |
| SCHEMBL961085 | 0.77 | MAP2K1 (0.83) | MAP2K1RAF1CYP3A4CYP2C9 | |
| SCHEMBL14048890 | 0.76 | MAP2K1 (0.85) | MAP2K1RAF1CYP3A4CYP2C9 | |
| SCHEMBL960164 | 0.76 | MAP2K1 (1.00) | MAP2K1RAF1CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1982982-A1 | NOVEL COUMARIN DERIVATIVE HAVING ANTITUMOR ACTIVITY | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2008-10-22 | — | — | EP | disclosed |